MX2009012612A - Purinonas e inhibidores 1h-imidazopiridinonas como pkc-theta. - Google Patents
Purinonas e inhibidores 1h-imidazopiridinonas como pkc-theta.Info
- Publication number
- MX2009012612A MX2009012612A MX2009012612A MX2009012612A MX2009012612A MX 2009012612 A MX2009012612 A MX 2009012612A MX 2009012612 A MX2009012612 A MX 2009012612A MX 2009012612 A MX2009012612 A MX 2009012612A MX 2009012612 A MX2009012612 A MX 2009012612A
- Authority
- MX
- Mexico
- Prior art keywords
- imidazopyridinones
- purinones
- pkc
- theta inhibitors
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2007/069530 WO2008143674A1 (en) | 2007-05-23 | 2007-05-23 | Purinones and 1h-imidazopyridinones as pkc-theta inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009012612A true MX2009012612A (es) | 2009-12-07 |
Family
ID=39262569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009012612A MX2009012612A (es) | 2007-05-23 | 2007-05-23 | Purinonas e inhibidores 1h-imidazopiridinonas como pkc-theta. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2152708A1 (ja) |
JP (1) | JP2010527999A (ja) |
CN (1) | CN101679412A (ja) |
CA (1) | CA2686485A1 (ja) |
MX (1) | MX2009012612A (ja) |
WO (1) | WO2008143674A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7989459B2 (en) * | 2006-02-17 | 2011-08-02 | Pharmacopeia, Llc | Purinones and 1H-imidazopyridinones as PKC-theta inhibitors |
AR063141A1 (es) | 2006-10-04 | 2008-12-30 | Pharmacopeia Inc | Derivados de 2- ( benzimidazolil ) purina 8- sustituida para inmunosupresion |
US7902187B2 (en) | 2006-10-04 | 2011-03-08 | Wyeth Llc | 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
WO2008043031A1 (en) | 2006-10-04 | 2008-04-10 | Pharmacopeia, Inc. | 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
WO2009062059A2 (en) * | 2007-11-08 | 2009-05-14 | Pharmacopeia, Inc. | Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors |
PA8851101A1 (es) | 2008-12-16 | 2010-07-27 | Lilly Co Eli | Compuesto amino pirazol |
RU2553681C2 (ru) | 2009-10-29 | 2015-06-20 | Вектура Лимитед | N-содержащие гетероарильные производные в качестве ингибиторов jak3 киназы |
GB201321737D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
US10189841B2 (en) | 2015-11-20 | 2019-01-29 | Forma Therapeutics, Inc. | Purinones as ubiquitin-specific protease 1 inhibitors |
KR20210057014A (ko) * | 2018-09-13 | 2021-05-20 | 깃세이 야쿠힌 고교 가부시키가이샤 | 이미다조피리디논 화합물 |
JP7383818B2 (ja) * | 2019-11-25 | 2023-11-20 | ザイ ラボ (シャンハイ) カンパニー、リミテッド. | Dna-pk阻害剤としてのピリミドイミダゾル系化合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020063854A (ko) | 1999-09-17 | 2002-08-05 | 애보트 게엠베하 운트 콤파니 카게 | 치료제로서의 키나제 억제제 |
CA2598076A1 (en) * | 2005-02-16 | 2006-08-24 | Astrazeneca Ab | Chemical compounds |
EP1874772A1 (en) | 2005-04-05 | 2008-01-09 | Pharmacopeia, Inc. | Purine and imidazopyridine derivatives for immunosuppression |
DE102005042742A1 (de) | 2005-09-02 | 2007-03-08 | Schering Ag | Substituierte Imidazo[1,2b]pyridazine als Kinase-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel |
WO2007035873A1 (en) | 2005-09-21 | 2007-03-29 | Pharmacopeia, Inc. | Purinone derivatives for treating neurodegenerative diseases |
-
2007
- 2007-05-23 EP EP07797679A patent/EP2152708A1/en not_active Withdrawn
- 2007-05-23 JP JP2010509317A patent/JP2010527999A/ja active Pending
- 2007-05-23 CN CN200780053087A patent/CN101679412A/zh active Pending
- 2007-05-23 MX MX2009012612A patent/MX2009012612A/es not_active Application Discontinuation
- 2007-05-23 WO PCT/US2007/069530 patent/WO2008143674A1/en active Application Filing
- 2007-05-23 CA CA002686485A patent/CA2686485A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2008143674A1 (en) | 2008-11-27 |
EP2152708A1 (en) | 2010-02-17 |
CN101679412A (zh) | 2010-03-24 |
JP2010527999A (ja) | 2010-08-19 |
CA2686485A1 (en) | 2008-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009012612A (es) | Purinonas e inhibidores 1h-imidazopiridinonas como pkc-theta. | |
WO2009062059A3 (en) | Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors | |
MX2009004154A (es) | Purinas como inhibidores de pkc-theta. | |
MY153915A (en) | Organic compounds | |
MX2010003918A (es) | Compuesto de amida. | |
WO2008025856A3 (en) | Modified glycoproteins | |
MX341133B (es) | Compuestos y metodos para la inhibición de hdac. | |
MX2009005934A (es) | Compuestos organicos. | |
GB0508318D0 (en) | Organic compounds | |
UA103625C2 (en) | 5-hetrocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enons as herbicides | |
TW200716543A (en) | Chemical compounds VII | |
MX2011007998A (es) | Nuevos herbicidas. | |
MY161132A (en) | Novel herbicides | |
MX341456B (es) | Amino-quinolinas como inhibidores de cinasa. | |
MX2012008738A (es) | Microorganismos y metodos para la biosintesis de p-toluato y tereftalato. | |
GB0508314D0 (en) | Organic compounds | |
MX2011007932A (es) | Herbicidas nuevos. | |
UA102289C2 (ru) | Гербициды, полученные из циклопентадиона | |
MX2012008141A (es) | Compuestos y metodos. | |
MX2012007341A (es) | Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso. | |
MX2010001093A (es) | Herbicidas novedosos. | |
MX2012006696A (es) | Derivados de 3, 4, 4a, 10b-tetrahidro-1h-tiopirano-[4, 3-c]-isoqunolina. | |
WO2009074741A3 (fr) | Nouveau procede de synthese du ranelate de strontium et de ses hydrates | |
MY146671A (en) | Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents | |
TN2009000536A1 (en) | Novel herbicides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |